In Brief: Geoffrey Levitt
Geoffrey Levitt: D.C. food and drug law attorney leaves Buc, Levitt & Beardsley to join the Washington firm Venable, Attorneys at Law in Venable's Regulatory and Legislative Group. Levitt was with Weil, Gotshal & Manges before Buc, Levitt & Beardsley. He also has worked at the State Department and for the Council on Foreign Relations...
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth